09.12.2024
Publications category: Regulatory interactions
12.11.2024
Concentration-QTcF analysis of quizartinib in patients with newly diagnosed FLT3-internal-tandem-duplication-positive acute myeloid leukemia
17.04.2024
Covariate modeling in pharmacometrics: General points for consideration
15.12.2023
Concentration-QTcF Analysis of Quizartinib in Patients With Newly Diagnosed (ND) Acute Myeloid Leukemia (AML)
15.12.2023
Population Pharmacokinetics (PopPK) of Quizartinib and Its Active Metabolite AC886 in Patients (Pts) With Newly Diagnosed (ND) Acute Myeloid Leukemia (AML)
16.10.2023
Writing reports of modelling and simulation analysis: Our experience in the field of pharmacometrics
14.06.2023
How to Successfully Generate an Alternative Approach to a Thorough QT Study: GLPG1972 as an Example
14.06.2023
Applications of Physiologically Based Biopharmaceutics Modeling (PBBM) to Support Drug Product Quality: A Workshop Summary Report
14.06.2023
Applications of Clinically Relevant Dissolution Testing: Workshop Summary Report
14.06.2023
Dissolution and Translational Modeling Strategies Toward Establishing an In Vitro-In Vivo Link-a Workshop Summary Report
14.06.2023